Cargando…

Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function

AIMS: Chronic kidney disease (CKD) is common and cardiovascular disease (CVD) is its commonest complication. The apelin system is a potential therapeutic target for CVD but data relating to apelin in CKD are limited. We examined expression of the apelin system in human kidney, and investigated apeli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nyimanu, Duuamene, Chapman, Fiona A., Gallacher, Peter J., Kuc, Rhoda E., Williams, Thomas L., Newby, David E., Maguire, Janet J., Davenport, Anthony P., Dhaun, Neeraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796317/ https://www.ncbi.nlm.nih.gov/pubmed/35748053 http://dx.doi.org/10.1111/bcp.15446

Ejemplares similares

The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021)

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

In vitro metabolism of synthetic Elabela/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA
por: Nyimanu, Duuamene, et al.
Publicado: (2021)

Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10
por: Owen, Nicola E., et al.
Publicado: (2021)

Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
por: Read, Cai, et al.
Publicado: (2021)

Trans-myocardial Extraction of Endothelin-1 Correlates with Increased Microcirculatory Resistance following Percutaneous Coronary Intervention
por: Abraham, George R., et al.
Publicado: (2022)

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019)

Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2019)

Correction to: Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2020)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands
por: Williams, Thomas L., et al.
Publicado: (2023)

Cardiac action of the first G protein biased small molecule apelin agonist
por: Read, Cai, et al.
Publicado: (2016)

International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
por: Read, Cai, et al.
Publicado: (2019)

[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017)

Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization
por: Farrah, Tariq E., et al.
Publicado: (2021)

Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes
por: Macrae, Robyn G C, et al.
Publicado: (2022)

Utility of interval kidney biopsy in ANCA-associated vasculitis
por: Chapman, Gavin B, et al.
Publicado: (2021)

Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function
por: Janssens, Peter, et al.
Publicado: (2023)

Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial
por: Gallacher, Peter J., et al.
Publicado: (2021)

Extracellular RNA in kidney disease: moving slowly but surely from bench to bedside
por: Hunter, Robert W., et al.
Publicado: (2020)

Infective Endocarditis Hospitalizations and Outcomes in Patients With End‐Stage Kidney Disease: A Nationwide Data‐Linkage Study
por: Gallacher, Peter J., et al.
Publicado: (2021)

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection
por: Williams, Thomas L., et al.
Publicado: (2021)

Apelin affects the mouse aging urinary peptidome with minimal effects on kidney
por: Vinel, Claire, et al.
Publicado: (2019)

Arterial stiffness & Sri Lankan chronic kidney disease of unknown origin
por: Gifford, Fiona, et al.
Publicado: (2016)

The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons
por: Farrah, Tariq E., et al.
Publicado: (2020)

Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study
por: Lambourg, Emilie J., et al.
Publicado: (2022)

Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system
por: Yang, Peiran, et al.
Publicado: (2015)

Serum elabela and apelin levels during different stages of chronic kidney disease
por: Lu, Xuehong, et al.
Publicado: (2020)

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease
por: Farrah, Tariq E., et al.
Publicado: (2019)

Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
por: Yang, Peiran, et al.
Publicado: (2017)

Risk Factors for Metabolic Syndrome Independently Predict Arterial Stiffness and Endothelial Dysfunction in Patients With Chronic Kidney Disease and Minimal Comorbidity
por: Lilitkarntakul, Pajaree, et al.
Publicado: (2012)

Acute kidney injury in children with chronic kidney disease is associated with faster decline in kidney function
por: Melhem, Nabil, et al.
Publicado: (2020)

Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease
por: Nordholm, Anders, et al.
Publicado: (2023)

Impact of Pregnancy on GFR Decline and Kidney Histology in Kidney Transplant Recipients
por: Kattah, Andrea G., et al.
Publicado: (2021)

Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney disease
por: Anand, Atul, et al.
Publicado: (2020)

Apelin-13 alleviates contrast-induced acute kidney injury by inhibiting endoplasmic reticulum stress
por: Liu, Qian, et al.
Publicado: (2023)

Editorial: The developing kidney: Perinatal aspects and relevance throughout life
por: Allegaert, Karel, et al.
Publicado: (2022)

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension
por: Hanratty, Rebecca, et al.
Publicado: (2009)

Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates
por: Husain, S. Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0lt5mdnut1vfc5ct2is190uq0v